Back to User profile » Professor David MG Halpin

Papers published by Professor David MG Halpin:


Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial

Halpin DM, Kendall R, Shukla S, Martin A, Shah D, Midwinter D, Beeh KM, Kocks JWH, Jones PW, Compton C, Risebrough NA, Ismaila AS

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2745-2755

Published Date: 25 October 2022

Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting

Halpin DM, Rothnie KJ, Banks V, Czira A, Compton C, Wood R, Tritton T, Massey O, Wild R, Snowise N, Nikitin K, Sharma R, Ismaila AS, Vogelmeier CF

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2417-2429

Published Date: 24 September 2022

Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial

Gabrio A, Gunsoy NB, Baio G, Martin A, Paly VF, Risebrough N, Halpin DMG, Singh D, Wise RA, Han MK, Martinez FJ, Criner GJ, Martin N, Lipson DA, Ismaila AS

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1633-1642

Published Date: 25 July 2022

Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation

Hanania NA, Maspero JF, Halpin DM, Jackson DJ, Panettieri RA, Castro M, Domingo C, Daizadeh N, Gall R, Jacob-Nara JA, Ortiz B, Djandji M, Rowe PJ, Deniz Y

Journal of Asthma and Allergy 2022, 15:851-854

Published Date: 28 June 2022

Epidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses

Halpin DM, Rabe AP, Loke WJ, Grieve S, Daniele P, Hwang S, Forsythe A

Journal of Asthma and Allergy 2022, 15:811-825

Published Date: 17 June 2022

Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease

Ohar JA, Ferguson GT, Mahler DA, Drummond MB, Dhand R, Pleasants RA, Anzueto A, Halpin DMG, Price DB, Drescher GS, Hoy HM, Haughney J, Hess MW, Usmani OS

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:79-92

Published Date: 6 January 2022

Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients

Jones R, Davis A, Stanley B, Julious S, Ryan D, Jackson DJ, Halpin DMG, Hickman K, Pinnock H, Quint JK, Khunti K, Heaney LG, Oliver P, Siddiqui S, Pavord I, Jones DHM, Hyland M, Ritchie L, Young P, Megaw T, Davis S, Walker S, Holgate S, Beecroft S, Kemppinen A, Appiagyei F, Roberts EJ, Preston M, Hardjojo A, Carter V, van Melle M, Price D

Pragmatic and Observational Research 2021, 12:93-104

Published Date: 11 August 2021

Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes

Price D, Jones R, Pfister P, Cao H, Carter V, Kemppinen A, Holzhauer B, Kaplan A, Clark A, Halpin DMG, Pinnock H, Chalmers JD, van Boven JF, Beeh KM, Kostikas K, Roche N, Usmani OA, Mastoridis P

Pragmatic and Observational Research 2021, 12:25-35

Published Date: 24 May 2021

Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD

Bourbeau J, Bafadhel M, Barnes NC, Compton C, Di Boscio V, Lipson DA, Jones PW, Martin N, Weiss G, Halpin DMG

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:499-517

Published Date: 1 March 2021

A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD

Ming SWY, Haughney J, Ryan D, Small I, Lavorini F, Papi A, Singh D, Halpin DMG, Hurst JR, Patel S, Ochel M, Kocks J, Carter V, Hardjojo A, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:3093-3103

Published Date: 26 November 2020

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial

Ismaila AS, Risebrough N, Schroeder M, Shah D, Martin A, Goodall EC, Ndirangu K, Criner G, Dransfield M, Halpin DMG, Han MK, Lomas DA

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2681-2695

Published Date: 29 November 2019

Impact and prevention of severe exacerbations of COPD: a review of the evidence

Halpin DMG, Miravitlles M, Metzdorf N, Celli B

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2891-2908

Published Date: 5 October 2017

When is dual bronchodilation indicated in COPD?

Thomas M, Halpin DMG, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2291-2305

Published Date: 3 August 2017

Preference for different relaxation techniques by COPD patients: comparison between six techniques

Hyland ME, Halpin DMG, Blake S, Seamark C, Pinnuck M, Ward D, Whalley B, Greaves CJ, Hawkins AL, Seamark D

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2315-2319

Published Date: 19 September 2016

Diagnosis, assessment, and phenotyping of COPD: beyond FEV1

Lange P, Halpin DM, O’Donnell DE, MacNee W

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:3-12

Published Date: 18 February 2016

Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis

Halpin DMG, Dahl R, Hallmann C, Mueller A, Tashkin D

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:239-259

Published Date: 5 February 2015

Exacerbation frequency and course of COPD

Halpin DMG, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:653-661

Published Date: 21 September 2012